Exosomes Market Outlook - 2027
Exosomes particularly referred as the extracellular vesicles that contain constituents like proteins, nucleic acids, DNA, RNA, lipids, metabolites, of the cells that secrete them. They are actually taken up by the distant cells, in which they play different functions with various behavior. They are different from the ectosomes as they are vesicles with the size range of around 40 to 160 nm and the ectosomes are the vesicles with the size range of around 50nm to 1 micrometer. It is used to maintain the homeostasis balance by removing the unnecessary constituents from the cells. It delivers diverse therapeutic payloads including short interfering RNAs, chemotherapeutic agents, antisense oligonucleotides and immune modulators, by an ability to direct the delivery to a desired target. Furthermore, exosome-based liquid biopsy finds its use in diagnosis and determination of the prognosis of the patients with cancer and other disease. The multicomponent analysis of them can also help in finding out the disease progression and response to therapy. Actually, they pose a potential to be a carrier for drug delivery for the target site. They have high biocompatibility and long-term circulation in the body. Likewise, they have various properties, which make them agents that may provide the treatment for various disorders.
COVID-19 Market Scenario Analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine, have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Top impacting factors: Market Scenario Analysis, Trends, Drivers, Impact Analysis
Increasing prevalence of diseases such as cancer and other types of diseases, are expected to drive the growth of the market. Moreover, technological advancements in the exosome isolation and analytical procedure also boost the growth of the market. Furthermore, rise in the health care expenditure also increases the level of the market. In addition, increase in cancer R&D can fuel the growth of the market. The spread of awareness about healthcare among the population is also helping to increase the growth of the exosomes market.
However, the technical difficulties in the implementation of exosomes for various tasks and strict regulatory requirements for the approval of the exosomes products in the market are expected to hamper the growth of the exosomes market.
New product launches to flourish the market:
In August 2020, the filing of an extended FDA investigational new drug application for studying the treatment of the COVID-19 related inflammatory disease using the Kimera’s First in Class XoGlo isolated placental mesenchymal stem cell-based exosomes was announced by the Kimera Labs.
In June 2020, a global research and option agreement for designing the well-engineered exosome therapeutics to deliver gene therapy, gene editing, RNA technologies of rare diseases were announced by the Sarepta Therapeutics.
Surge in the usage of the exosomes:
Increase in prevalence of cancer and other types of disease is helping to increase the usage of the exosomes. Moreover, the increase in the technical advancements also helps to surge the usage of exosomes.
Key benefits of the report:
- This study presents the analytical depiction of the global exosomes industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global exosomes market share.
- The current market is quantitatively analyzed to highlight the global exosomes market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global exosomes market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the exosomes market research report:
- What are the leading market players active in the exosomes market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Exosomes Market Report Highlights
| Aspects | Details |
 By Type and Service |
|
 By Biomolecule Type |
|
 By Application |
|
 By Region |
|
 Key Market Players | Diagenode SA, Hansa BioMed Life Sciences Hitachi Chemical Diagnostics, Inc., others., Lonza Group AG, Qiagen N.V., MBL International Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Miltenyi Biotec, Novus Biologicals, Evox Therapeutics Limited Fujifilm Holdings Corporation |
Loading Table Of Content...
